Biologics/Biosimilars

(O) Depression, Anxiety and Adjustment Disorder Among Patients with Psoriasis Receiving Systemic Agents: A Retrospective Cohort Study in Quebec, Canada

(Q) Effect Modification by Indications to The Risks of Major Thromboembolic Adverse Events in Patients Receiving Intravitreal Anti-Vascular Endothelial Growth Factor Treatment – a Population-Based Retrospective Cohort Study

(P) Inpatient Constipation Among Migraine Patients Treated with Preventive Medications in a United States Electronic Health Record Database

(R) Mandatory Non-Medical Switching Policy from Originator to Biosimilar Infliximab in Patients with Inflammatory Bowel Disease in British Columbia: A Cohort Study

(T) Predictors of Treatment Changes in Patients with Rheumatoid Arthritis Using Machine Learning

(S) TNF-Alpha Inhibitors Biosimilar Use in France: A 207,118 Patients Longitudinal Study

(12) A Regulatory Overview of Biosimilars Across Selected Countries

(15) Assessment of The Issues on Understanding and Use of Biologics in Clinical Practice and Their Regulations

(8) Brodalumab Assessment of Hazards: A Multinational Safety (BRAHMS) Study of a Biological Anti-Psoriatic Drug Across Six European Countries

(4) Comparative Risk of Herpes Zoster and Postherpetic Neuralgia in Patients with Psoriasis Receiving IL-17 Inhibitor and IL-12/23 Inhibitor Versus Traditional Systemic Immunosuppressants

(5) Evaluation of The Effectiveness and Safety of Biological Disease-Modifying Drugs for The Treatment of Ankylosing Spondylitis in The Unified Health System

(6) Evaluation of The Rate of Discontinuation of Treatment with Biological Drugs in Patients with Ankylosing Spondylitis: Pre-Pandemic and Pandemic Period

(7) Evaluation of The Use Profile of Biological Medicines and Synthetic Target-Specific Medicines for The Treatment of Rheumatoid Arthritis in The Sus in The State of Minas Gerais, Brazil

(10) Exploring The Relationship Between Utilization Patterns of Biologic Disease-Modifying Anti-Rheumatic Drugs and Disease Activity in Rheumatoid Arthritis Patients

(13) Real-World Effectiveness and Persistence of Methotrexate Versus Adalimumab: A Comparative Study from The British Association of Dermatologists Biologics and Immunomodulators Register (BADBIR)

(14) Recent Biosimilar Uptake in the United States

(2) Rheumatoid Arthritis, Psoriasis and Other Auto Immune Diseases - Prescribing Patterns and Characteristics of Patients Undergoing Biological Therapy in Portugal (2020)

(11) The Risk of Serious Infection in Crohn's Disease Patients Treated with Biologics: An External Comparator Cohort Study

(9) Traceability of Insulin Glargine's Innovator and Its Biosimilar Products Adverse Drug Events Reports in Saudi Arabia

(3) Trends in The Use of Biologics for Treatment of Plaque Psoriasis in The Real-World Setting

(1) Developing and Testing of Diagnostic Algorithms for The Identification of Inflammatory Bowel Diseases Using a Claims Database from Southern Italy